Boston venture capital firm Third Rock Ventures announced the launch of a genomic search engine company in strategic partnership with Sanofi SA, the French drug maker that recently bought Genzyme Corp. of Cambridge for $20.1 billion. The new company --- Warp Drive Bio --- will have $125 million in initial financing. Alexis Borisy, partner at Third Rock Ventures, is the interim chief executive officer of Warp Drive Bio.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help